早期结肠直肠癌生存率的种族和民族差异
Joshua Demb1,2, Scarlett L Gomez3,4, Alison J Canchola3
1Division of Gastroenterology, Department of Internal Medicine, University of California, San Diego, La Jolla.
JAMA network open
|November 22, 2024
概括
早期结直肠癌 (EOCRC) 死亡率在夏威夷原住民或其他太平洋岛民和非西班牙裔黑人人口中较高. 健康的社会决定因素导致了EOCRC结果的这些差异.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 健康差异 在健康上的差异
背景情况:
- 早期结直肠癌 (EOCRC) 的发病率正在上升,种族和民族之间存在显著差异.
- 关于EOCRC死亡率差异的数据有限,特别是在对少数群体进行分类时.
研究的目的:
- 调查EOCRC死亡率中的种族和民族差异.
- 分析临床和社会人口学因素对这些死亡率差异的影响.
- 提供有关夏威夷原住民或其他太平洋岛民以及各种亚裔美国人群体的具体数据.
主要方法:
- 基于人口的队列研究,使用加利福尼亚癌症登记数据 (2000-2019).
- 包括被诊断患有EOCRC的18-49岁的个人.
- 考克斯比例危险回归模型被用于评估种族/种族和死亡率之间的关联,并对共变量进行了顺序调整.
主要成果:
- 与非西班牙裔白人个人相比,在夏威夷原住民或其他太平洋岛民 (AHR, 1.34) 和非西班牙裔黑人 (AHR, 1.18) 群体中观察到较高的EOCRC死亡率.
- 在最初的模型中,西班牙裔个体的死亡率较高,但在调整邻里社会经济地位后,这种情况消失了.
- 亚裔美国人群体的分类显示异质性,在完全调整后,没有一个单一群体显示死亡率增加.
结论:
- EOCRC死亡率的种族和种族差异很大,特别影响了夏威夷原住民或其他太平洋岛民和非西班牙裔黑人个体.
- 健康的社会决定因素在解释这些观察到的死亡率差异方面发挥着至关重要的作用.
- 需要针对社会和经济因素的有针对性的干预措施来减少EOCRC的差异.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Comparing the Survival Analysis of Two or More Groups
152
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
152
Cancers Originate from Somatic Mutations in a Single Cell
11.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.6K
Assumptions of Survival Analysis
97
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
97
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Censoring Survival Data
63
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
63


